A major advance in cancer research is emerging with the use of mini-antibodies to restore dysfunctional p53. This essential cancer inhibitor protein is frequently disabled in many types of malignancies, causing https://bookmarkinglife.com/story7655975/vhh-fragments-revive-p53-a-potential-hope-for-malignant-treatment